collection
https://read.qxmd.com/read/32409703/diabetic-ketoacidosis
#1
REVIEW
Ketan K Dhatariya, Nicole S Glaser, Ethel Codner, Guillermo E Umpierrez
Diabetic ketoacidosis (DKA) is the most common acute hyperglycaemic emergency in people with diabetes mellitus. A diagnosis of DKA is confirmed when all of the three criteria are present - 'D', either elevated blood glucose levels or a family history of diabetes mellitus; 'K', the presence of high urinary or blood ketoacids; and 'A', a high anion gap metabolic acidosis. Early diagnosis and management are paramount to improve patient outcomes. The mainstays of treatment include restoration of circulating volume, insulin therapy, electrolyte replacement and treatment of any underlying precipitating event...
May 14, 2020: Nature Reviews. Disease Primers
https://read.qxmd.com/read/32780104/managing-electrolyte-disorders-order-a-basic-urine-metabolic-panel
#2
EDITORIAL
Richard H Sterns
No abstract text is available yet for this article.
November 1, 2020: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/32651852/critical-care-ultrasonography-in-shock-management-the-elephant-in-canadian-intensive-care-units
#3
EDITORIAL
John Basmaji, Ian Ball, Philip Jones, Bram Rochwerg, Robert Arntfield
No abstract text is available yet for this article.
September 2020: Canadian Journal of Anaesthesia
https://read.qxmd.com/read/32699043/management-of-lupus-nephritis-a-systematic-literature-review-informing-the-2019-update-of-the-joint-eular-and-european-renal-association-european-dialysis-and-transplant-association-eular-era-edta-recommendations
#4
JOURNAL ARTICLE
Myrto Kostopoulou, Antonis Fanouriakis, Kim Cheema, John Boletis, George Bertsias, David Jayne, Dimitrios T Boumpas
OBJECTIVES: To analyse the current evidence for the management of lupus nephritis (LN) informing the 2019 update of the EULAR/European Renal Association-European Dialysis and Transplant Association recommendations. METHODS: According to the EULAR standardised operating procedures, a PubMed systematic literature review was performed, from January 1, 2012 to December 31, 2018. Since this was an update of the 2012 recommendations, the final level of evidence (LoE) and grading of recommendations considered the total body of evidence, including literature prior to 2012...
July 2020: RMD Open
https://read.qxmd.com/read/32663831/etiology-and-management-of-acute-metabolic-acidosis-an-update
#5
JOURNAL ARTICLE
Igor Matyukhin, Susann Patschan, Oliver Ritter, Daniel Patschan
BACKGROUND: The etiology of acute metabolic acidosis (aMA) is heterogeneous, and the consequences are potentially life-threatening. The aim of this article was to summarize the causes and management of aMA from a clinician's perspective. SUMMARY: We performed a systematic search on PubMed, applying the following search terms: "acute metabolic acidosis," "lactic acidosis," "metformin" AND "acidosis," "unbalanced solutions" AND "acidosis," "bicarbonate" AND "acidosis" AND "outcome," "acute metabolic acidosis" AND "management," and "acute metabolic acidosis" AND "renal replacement therapy (RRT)/dialysis...
2020: Kidney & Blood Pressure Research
https://read.qxmd.com/read/32062853/tramadol-diclofenac-fixed-dose-combination-a-review-of-its-use-in-severe-acute-pain
#6
REVIEW
Dilip D Shah, Zubair H Sorathia
Pain is a health issue affecting all populations, regardless of age, gender, economic status, race, or geography. Acute pain is the most common type of pain, with a complex aetiology. Inadequately managed acute pain adversely affects quality of life and imposes significant economic burden. The majority of the available pain-relieving drugs have monomodal mechanisms of analgesia, which necessitates combining drugs with non-redundant mechanisms of action in order to provide adequate pain relief and reduce the side effects from higher doses of individual drugs...
June 2020: Pain and Therapy
https://read.qxmd.com/read/32729812/nervous-system-involvement-in-coronavirus-disease-2019-results-from-a-retrospective-consecutive-neuroimaging-cohort
#7
JOURNAL ARTICLE
Stefanos Klironomos, Antonios Tzortzakakis, Annika Kits, Claes Öhberg, Evangelia Kollia, Amir Ahoromazdae, Håkan Almqvist, Åsa Aspelin, Heather Martin, Russell Ouellette, Jonathan Al-Saadi, Mikael Hasselberg, Mansour Haghgou, Mitra Pedersen, Sven Petersson, Johannes Finnsson, Johan Lundberg, Anna Falk Delgado, Tobias Granberg
Background Neurologic complications in coronavirus disease 2019 (COVID-19) have been described, but the understanding of their pathophysiologic causes and neuroanatomical correlates remains limited. Purpose To report on the frequency and type of neuroradiological findings in COVID-19. Materials and Methods In this retrospective study, all consecutive adult hospitalized patients with polymerase chain reaction positivity for severe acute respiratory syndrome coronavirus 2 and who underwent neuroimaging at Karolinska University Hospital between March 2 and May 24, 2020, were included...
December 2020: Radiology
https://read.qxmd.com/read/32508672/recent-advances-in-the-treatment-of-sickle-cell-disease
#8
REVIEW
Gabriel Salinas Cisneros, Swee L Thein
Sickle cell anemia (SCA) was first described in the Western literature more than 100 years ago. Elucidation of its molecular basis prompted numerous biochemical and genetic studies that have contributed to a better understanding of its pathophysiology. Unfortunately, the translation of such knowledge into developing treatments has been disproportionately slow and elusive. In the last 10 years, discovery of BCL11A , a major γ-globin gene repressor, has led to a better understanding of the switch from fetal to adult hemoglobin and a resurgence of efforts on exploring pharmacological and genetic/genomic approaches for reactivating fetal hemoglobin as possible therapeutic options...
2020: Frontiers in Physiology
https://read.qxmd.com/read/32223716/diagnosis-and-management-of-covid-19-disease
#9
JOURNAL ARTICLE
Shazia Jamil, Nick Mark, Graham Carlos, Charles S Dela Cruz, Jane E Gross, Susan Pasnick
No abstract text is available yet for this article.
May 15, 2020: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/32159735/care-for-critically-ill-patients-with-covid-19
#10
JOURNAL ARTICLE
Srinivas Murthy, Charles D Gomersall, Robert A Fowler
No abstract text is available yet for this article.
April 21, 2020: JAMA
https://read.qxmd.com/read/31990655/sepsis-and-septic-shock-guideline-based-management
#11
REVIEW
Siddharth Dugar, Chirag Choudhary, Abhijit Duggal
Sepsis is a life-threatening organ dysfunction that results from the body's response to infection. It requires prompt recognition, appropriate antibiotics, careful hemodynamic support, and control of the source of infection. With the trend in management moving away from protocolized care in favor of appropriate usual care, an understanding of sepsis physiology and best practice guidelines is critical.
January 2020: Cleveland Clinic Journal of Medicine
https://read.qxmd.com/read/31863457/understanding-volume-kinetics
#12
REVIEW
Robert G Hahn
The distribution and elimination kinetics of the water volume in infusion fluids can be studied by volume kinetics. The approach is a modification of drug pharmacokinetics and uses repeated measurements of blood hemoglobin and urinary excretion as input variables in (usually) a two-compartment model with expandable walls. Study results show that crystalloid fluid has a distribution phase that gives these fluids a plasma volume expansion amounting to 50%-60% of the infused volume as long as the infusion lasts, while the fraction is reduced to 15%-20% within 30 minutes after the infusion ends...
May 2020: Acta Anaesthesiologica Scandinavica
https://read.qxmd.com/read/31842915/how-i-set-up-positive-end-expiratory-pressure-evidence-and-physiology-based
#13
EDITORIAL
Emanuele Rezoagli, Giacomo Bellani
No abstract text is available yet for this article.
December 16, 2019: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/31857443/2019-update-to-management-of-hyperglycemia-in-type-2-diabetes-2018-a-consensus-report-by-the-american-diabetes-association-ada-and-the-european-association-for-the-study-of-diabetes-easd
#14
JOURNAL ARTICLE
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies
The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of hyperglycemia, based on important research findings from large cardiovascular outcomes trials published in 2019. Important changes include: 1 ) the decision to treat high-risk individuals with a glucagon-like peptide 1 (GLP-1) receptor agonist or sodium-glucose cotransporter 2 (SGLT2) inhibitor to reduce major adverse cardiovascular events (MACE), hospitalization for heart failure (hHF), cardiovascular death, or chronic kidney disease (CKD) progression should be considered independently of baseline HbA1c or individualized HbA1c target; 2 ) GLP-1 receptor agonists can also be considered in patients with type 2 diabetes without established cardiovascular disease (CVD) but with the presence of specific indicators of high risk; and 3 ) SGLT2 inhibitors are recommended in patients with type 2 diabetes and heart failure, particularly those with heart failure with reduced ejection fraction, to reduce hHF, MACE, and CVD death, as well as in patients with type 2 diabetes with CKD (estimated glomerular filtration rate 30 to ≤60 mL min-1 [1...
February 2020: Diabetes Care
https://read.qxmd.com/read/31800080/hyperkalemia-pathophysiology-risk-factors-and-consequences
#15
REVIEW
Robert W Hunter, Matthew A Bailey
There have been significant recent advances in our understanding of the mechanisms that maintain potassium homoeostasis and the clinical consequences of hyperkalemia. In this article we discuss these advances within a concise review of the pathophysiology, risk factors and consequences of hyperkalemia. We highlight aspects that are of particular relevance for clinical practice. Hyperkalemia occurs when renal potassium excretion is limited by reductions in glomerular filtration rate, tubular flow, distal sodium delivery or the expression of aldosterone-sensitive ion transporters in the distal nephron...
December 1, 2019: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/31791953/management-of-severe-acute-pancreatitis
#16
REVIEW
O Joe Hines, Stephen J Pandol
The risks, measurements of severity, and management of severe acute pancreatitis and its complications have evolved rapidly over the past decade. Evidence suggests that initial goal directed therapy, nutritional support, and vigilance for pancreatic complications are best practice. Patients can develop pancreatic fluid collections including acute pancreatic fluid collections, pancreatic pseudocysts, acute necrotic collections, and walled-off necrosis. Several randomized controlled trials and cohort studies have recently highlighted the advantage of managing these conditions with a progressive approach, with initial draining for infection followed by less invasive techniques...
December 2, 2019: BMJ: British Medical Journal
https://read.qxmd.com/read/31541214/diagnosis-and-management-of-guillain-barr%C3%A3-syndrome-in-ten-steps
#17
REVIEW
Sonja E Leonhard, Melissa R Mandarakas, Francisco A A Gondim, Kathleen Bateman, Maria L B Ferreira, David R Cornblath, Pieter A van Doorn, Mario E Dourado, Richard A C Hughes, Badrul Islam, Susumu Kusunoki, Carlos A Pardo, Ricardo Reisin, James J Sejvar, Nortina Shahrizaila, Cristiane Soares, Thirugnanam Umapathi, Yuzhong Wang, Eppie M Yiu, Hugh J Willison, Bart C Jacobs
Guillain-Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics in 2013 in French Polynesia and 2015 in Latin America. Diagnosis and management of GBS can be complicated as its clinical presentation and disease course are heterogeneous, and no international clinical guidelines are currently available...
September 20, 2019: Nature Reviews. Neurology
https://read.qxmd.com/read/31443997/acute-kidney-injury-from-sepsis-current-concepts-epidemiology-pathophysiology-prevention-and-treatment
#18
REVIEW
Sadudee Peerapornratana, Carlos L Manrique-Caballero, Hernando Gómez, John A Kellum
Sepsis-associated acute kidney injury (S-AKI) is a frequent complication of the critically ill patient and is associated with unacceptable morbidity and mortality. Prevention of S-AKI is difficult because by the time patients seek medical attention, most have already developed acute kidney injury. Thus, early recognition is crucial to provide supportive treatment and limit further insults. Current diagnostic criteria for acute kidney injury has limited early detection; however, novel biomarkers of kidney stress and damage have been recently validated for risk prediction and early diagnosis of acute kidney injury in the setting of sepsis...
November 2019: Kidney International
https://read.qxmd.com/read/31418093/diagnosis-and-management-of-metabolic-acidosis-guidelines-from-a-french-expert-panel
#19
REVIEW
Boris Jung, Mikaël Martinez, Yann-Erick Claessens, Michaël Darmon, Kada Klouche, Alexandre Lautrette, Jacques Levraut, Eric Maury, Mathieu Oberlin, Nicolas Terzi, Damien Viglino, Youri Yordanov, Pierre-Géraud Claret, Naïke Bigé
Metabolic acidosis is a disorder frequently encountered in emergency medicine and intensive care medicine. As literature has been enriched with new data concerning the management of metabolic acidosis, the French Intensive Care Society (Société de Réanimation de Langue Française [SRLF]) and the French Emergency Medicine Society (Société Française de Médecine d'Urgence [SFMU]) have developed formalized recommendations from experts using the GRADE methodology. The fields of diagnostic strategy, patient assessment, and referral and therapeutic management were addressed and 29 recommendations were made: 4 recommendations were strong (Grade 1), 10 were weak (Grade 2), and 15 were experts' opinions...
August 15, 2019: Annals of Intensive Care
https://read.qxmd.com/read/31412127/oral-fluoroquinolone-or-trimethoprim-sulfamethoxazole-vs-%C3%A3-lactams-as-step-down-therapy-for-enterobacteriaceae-bacteremia-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Chitra Punjabi, Vivian Tien, Lina Meng, Stan Deresinski, Marisa Holubar
BACKGROUND: Using published data, we sought to compare outcomes in patients transitioned to either oral fluoroquinolones (FQ) or trimethoprim-sulfamethoxazole (TMP-SMX) versus ß-lactams (BL's) after an initial intravenous (IV) course for gram-negative rod (GNR) bacteremia. METHODS: We conducted a systematic review of PubMed and EMBASE and published IDWeek abstracts. We included studies that reported all-cause mortality and/or infection recurrence in patients transitioned to oral FQ/TMP-SMX and BL's...
August 14, 2019: Open Forum Infectious Diseases
label_collection
label_collection
8520
1
2
2019-09-01 12:48:04
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.